This Day On The Street
Continue to site
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

Jacqueline Lemke Named Interim President & CEO Of Bioanalytical Systems

BASi (Bioanalytical Systems, Inc.) (NASDAQ:BASI) announced today that CFO Jacqueline M. Lemke has been named to the additional posts of interim President & CEO. Ms. Lemke succeeds Anthony S. Chilton, Ph.D., who has resigned as CEO to pursue other opportunities.

"Jacqueline Lemke has demonstrated exceptional skill, energy and commitment since she joined BASi as CFO three months ago. In this short time she has significantly reduced the company's cost structure, refocused our marketing program, and instituted aggressive performance goals for all operating departments. Many more changes are in the works. As interim President and CEO, with continuing responsibility as CFO, we expect Jackie to complete the transformation of BASi and deliver the growth and profitability we believe this company is capable of delivering. Board member Richard Johnson and I, with more than 60 years of combined major pharma and CRO experience, will work closely with Jackie during this interim period," said John B. Landis, Ph.D., Chairman.

"BASi has provided drug development and discovery services to the pharmaceutical industry for more than 35 years. We have a superb and dedicated technical staff, world-class laboratory facilities, and we enjoy an outstanding reputation for the quality of our services and proprietary test instruments. With these critical building blocks in place, I believe we can improve the company's operating performance and restore revenue growth, and I am committed to making this happen," Ms. Lemke said.

Ms. Lemke has more than 20 years of experience in critical financial reporting and management positions, most recently as Vice President of Finance and Global CFO of Remy, Inc., a $900 million division of Remy International, where she built a 44-person global finance team and created a financial system to support rapid decision making and clear lines of management accountability. Earlier, she served as Vice President of Finance, Global CFO Connected Home Solutions at Motorola, Inc., and was Strategic Planning Director, Global Invista division at DuPont. Ms. Lemke is a CPA and began her career as a tax consultant at Deloitte Touche.

1 of 2

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free


Chart of I:DJI
DOW 16,852.79 +62.60 0.37%
S&P 500 1,995.39 +15.47 0.78%
NASDAQ 4,788.4690 +40.1080 0.84%

Free Reports

Top Rated Stocks Top Rated Funds Top Rated ETFs